Published: May 30, 2026
Written by Klarity Editorial Team
Published: May 30, 2026

If you’re struggling with binge eating disorder (BED), you might be wondering whether you can access treatment through telehealth—especially medications that can help manage symptoms. The good news: Yes, you absolutely can get BED medication through telehealth in every U.S. state, and it’s completely legal under current federal and state regulations.
This comprehensive guide breaks down everything you need to know about accessing binge eating disorder treatment online, from the medications available to state-specific regulations and what to expect during your telehealth visit.
The COVID-19 pandemic fundamentally changed how we access healthcare, and those changes have largely become permanent—especially for mental health and eating disorder treatment. For medications used to treat binge eating disorder, telehealth offers a safe, convenient, and fully legal pathway to care.
At the federal level, medications used for BED fall into a category that makes telehealth access straightforward. The two most commonly prescribed medications for binge eating disorder—topiramate (Topamax) and bupropion (Wellbutrin)—are non-controlled substances. This is crucial because it means they’re not subject to the strict in-person requirements that apply to controlled medications like ADHD stimulants or opioids.
The Ryan Haight Act, a 2008 federal law, requires an in-person medical evaluation before prescribing controlled substances via telehealth. However, this law never applied to non-controlled medications like those used for BED treatment. This means there’s no federal barrier preventing your doctor from prescribing these medications after a virtual evaluation.
Currently, the DEA has extended pandemic-era flexibilities for controlled substance prescribing through December 31, 2026, while working on permanent regulations. But for BED medications, these extensions don’t even matter—telehealth prescribing has always been allowed and remains fully accessible.
Topiramate is an anticonvulsant medication originally approved for seizures and migraines, but it’s frequently prescribed off-label for binge eating disorder. Research suggests it can help reduce binge frequency and support impulse control, which are core challenges in BED.
Key considerations for topiramate:
Bupropion is an atypical antidepressant FDA-approved for depression and smoking cessation, but studies have shown it can help reduce binge eating episodes in some patients.
Key considerations for bupropion:
You might notice that neither topiramate nor bupropion is FDA-approved specifically for binge eating disorder. The only FDA-approved medication for BED is lisdexamfetamine (Vyvanse), which is a controlled stimulant. Due to strict regulations around controlled substances and telehealth, most online providers focus on these well-researched, non-controlled alternatives.
Off-label prescribing is both legal and common in medicine, especially in mental health and eating disorder treatment. Clinical research supports the use of both topiramate and bupropion for BED, and your telehealth provider should explain the evidence, risks, and benefits before starting treatment.
While federal law permits telehealth prescribing of non-controlled medications, each state has its own additional regulations. Here’s what matters most for BED treatment access:
California, New York, Texas, Michigan, Wisconsin, South Carolina, and Florida have no state-mandated in-person visit requirement for prescribing non-controlled medications via telehealth. California has even clarified that asynchronous telehealth (like online questionnaires combined with messaging) can constitute an adequate evaluation if it meets the standard of care.
In these states, you can complete your entire evaluation, receive your prescription, and manage ongoing care entirely online—no physical office visit required.
Alabama, Georgia, and New Hampshire require some level of in-person follow-up for ongoing telehealth treatment:
Alabama: If you receive more than four telehealth visits for the same condition within 12 months, you must have an in-person exam within that year. This can be satisfied by seeing any collaborating provider in your area—not necessarily your telehealth prescriber.
Georgia: Requires attempting an in-person exam at least annually for continued telemedicine care. Initial evaluations can be done via telehealth if the technology allows for an examination equivalent to in-person.
New Hampshire: Allows telehealth prescribing of even Schedule II-IV controlled substances, but requires an in-person exam every 12 months for ongoing treatment. For non-controlled BED medications, this annual requirement applies to long-term treatment.
These requirements exist to ensure continuity of care and proper monitoring, but they’re designed to be flexible. Many patients find that an annual in-person visit with a local provider satisfies the requirement while maintaining the convenience of telehealth for regular appointments.
Delaware passed SB 101 in July 2025, specifically addressing telemedicine for substance use disorder treatment. While this primarily affects opioid use disorder medications, it reinforced the state’s commitment to telehealth access for mental health and eating disorder treatment as well.
MDs and DOs licensed in your state can prescribe topiramate or bupropion for binge eating disorder via telehealth in all 50 states. There are no additional restrictions beyond standard medical practice requirements.
The landscape for nurse practitioner (NP) prescribing authority has evolved dramatically. As of 2025, approximately 34 states plus Washington, D.C. grant NPs Full Practice Authority (FPA), meaning they can evaluate patients and prescribe medications independently without physician oversight.
States where NPs have independent prescribing authority include:
In states requiring collaborative agreements (like Texas, Florida, Georgia, and Alabama), NPs can still prescribe topiramate and bupropion for BED, but they must work under a formal agreement with a supervising physician. From a patient perspective, this rarely affects your care experience—it’s a regulatory requirement that happens behind the scenes.
PAs can prescribe these non-controlled medications in all states, though they typically work under supervising physician agreements. The level of autonomy varies by state, but for BED treatment via telehealth, qualified PAs can provide the same level of care as other prescribers.
A legitimate telehealth evaluation for binge eating disorder should be thorough and comprehensive—typically 30 minutes or longer for an initial consultation. Your provider will:
Review your eating behaviors in detail:
Assess your mental health history:
Review your medical history:
Discuss treatment goals and expectations:
Your telehealth provider will document that you meet DSM-5 criteria for binge eating disorder. They’ll obtain informed consent for telehealth treatment, which typically includes:
Many states require providers to verify your identity and location at the beginning of the visit. This isn’t invasive—it’s a legal requirement to ensure the provider is licensed in your state and to prevent fraud.
Prescription Monitoring Programs track controlled substance prescriptions to prevent abuse and ‘doctor shopping.’ Because topiramate and bupropion are non-controlled, most states don’t require PMP checks before prescribing them.
However, responsible telehealth providers may still review your medication history as part of good clinical practice—checking for potential drug interactions or ensuring you’re not receiving duplicate prescriptions from multiple providers.
While telehealth is appropriate for most people seeking BED treatment, certain situations require in-person evaluation:
Medical contraindications:
Treatment complexity:
At Klarity Health, we’ve built our platform around the principle that accessible care should never mean compromised care. Our approach to binge eating disorder treatment includes:
Thorough evaluations: Our licensed providers conduct comprehensive assessments that meet or exceed the standards you’d receive in a traditional office setting. We don’t rush through consultations—initial BED evaluations typically take 30-45 minutes.
Transparent pricing: We accept both insurance and cash pay options, with upfront pricing so you know exactly what to expect. No surprise bills or hidden fees.
Provider availability: We understand that eating disorders don’t follow a 9-to-5 schedule. Our providers offer flexible appointment times, including evenings and weekends, across all states where we operate.
Coordinated care approach: While medication can be an important tool, we recognize that BED treatment is most effective when it includes therapy, nutritional support, and lifestyle changes. We can connect you with additional resources and specialists as needed.
Ongoing monitoring: We schedule regular follow-up appointments to track your progress, adjust medications as needed, and address any side effects. You’re never left to manage treatment alone.
As telehealth has expanded, so have concerns about quality. Here’s what to watch for:
Red flags:
Good practices to look for:
Once your provider determines that medication is appropriate, they’ll send an electronic prescription to the pharmacy of your choice. This is now standard practice and required in many states.
What to expect:
Both topiramate and bupropion are typically covered by insurance when prescribed for any medically appropriate reason, including off-label uses. Your provider will code the visit and prescription appropriately (often using a mental health diagnosis code that includes BED).
Without insurance:
Many patients prefer the convenience of mail-order pharmacies, especially for ongoing prescriptions. This is perfectly acceptable—just ensure your telehealth provider is aware of your preferred pharmacy so they can send prescriptions to the correct location.
First month:
Months 2-3:
Long-term:
Contact your provider promptly if you experience:
During regular follow-ups, discuss:
While medications like topiramate and bupropion can help reduce binge eating episodes, research consistently shows that comprehensive treatment yields the best outcomes. This typically includes:
Evidence-based psychotherapy:
Nutritional counseling:
Support groups:
Lifestyle modifications:
Klarity Health can connect you with therapists and nutritionists who specialize in eating disorders, creating a coordinated care team that addresses all aspects of your recovery.
The telehealth landscape continues to evolve. Key developments on the horizon:
DEA permanent rulemaking: The DEA is expected to finalize permanent telehealth prescribing rules by the end of 2026. While this primarily affects controlled substances, it will shape the overall telehealth environment.
State scope of practice expansions: More states are moving toward full practice authority for nurse practitioners, which will increase access to qualified prescribers, especially in rural and underserved areas.
Interstate licensure compacts: Some states are exploring compacts that would allow providers licensed in one state to practice via telehealth in other compact states, potentially expanding access further.
Research into new medications for binge eating disorder continues. While Vyvanse remains the only FDA-approved option, ongoing studies are examining other medications that may become more accessible via telehealth in the future.
Can I get Vyvanse for BED through telehealth?
Vyvanse (lisdexamfetamine) is a Schedule II controlled substance, which currently has strict telehealth prescribing requirements under the temporary DEA rules. Most telehealth platforms do not prescribe it due to these restrictions and the in-person evaluation requirement that will likely return once the temporary extensions expire. However, the non-controlled alternatives discussed in this article—topiramate and bupropion—offer proven benefits for many people with BED.
Do I need to see a specialist, or can my regular doctor prescribe these medications?
Any licensed prescriber (MD, DO, NP, or PA) can prescribe topiramate or bupropion for BED if they’re comfortable with the diagnosis and treatment. However, working with a provider who specializes in eating disorders or has significant experience treating BED often leads to better outcomes, as they can provide comprehensive care and recognize nuances of the condition.
How long will I need to take medication for BED?
Treatment duration varies significantly based on individual response and circumstances. Some people benefit from 6-12 months of medication combined with therapy, while others may need longer-term treatment. This should be decided collaboratively with your provider based on your progress, symptom improvement, and overall recovery trajectory.
Will my insurance cover telehealth visits for BED?
Most insurance plans now cover telehealth visits at the same rate as in-person visits, especially for mental health and behavioral health conditions. However, coverage specifics vary by plan. Klarity Health can verify your insurance benefits before your first visit so you know exactly what to expect.
What if I live in a rural area with no eating disorder specialists nearby?
This is precisely where telehealth shines. You can access specialized BED treatment from providers anywhere in your state, regardless of your physical location. This is particularly valuable in rural and underserved areas where eating disorder specialists may be hours away.
Can I continue seeing my regular therapist while getting medication through telehealth?
Absolutely. In fact, this is encouraged. Your telehealth prescriber can coordinate with your existing therapist to provide integrated care. Many patients find that combining their established therapeutic relationship with medication management through a specialized platform like Klarity Health offers the best of both worlds.
If you’re struggling with binge eating disorder, you don’t have to wait months for an in-person appointment or travel hours to see a specialist. Telehealth offers immediate, accessible, and high-quality care that can start you on the path to recovery.
Gather relevant information:
Prepare your space:
Prepare your questions:
At Klarity Health, we’ve made it our mission to remove barriers to mental health and eating disorder treatment. Here’s what sets us apart:
The expansion of telehealth has transformed access to eating disorder treatment, making specialized care available to people who previously faced significant barriers. For binge eating disorder specifically, the legal landscape is clear: non-controlled medications like topiramate and bupropion can be safely and legally prescribed via telehealth in every U.S. state.
While regulations vary by state—with some requiring periodic in-person follow-ups and others allowing completely virtual care—the fundamental right to access treatment remotely is well-established and supported by current federal and state laws.
If you’re ready to take the first step toward recovery from binge eating disorder, telehealth offers a convenient, private, and effective pathway. With thorough evaluations, evidence-based treatment approaches, and ongoing monitoring, platforms like Klarity Health provide the quality care you deserve, delivered where and when you need it.
Ready to start your recovery journey? Connect with a licensed provider at Klarity Health today. Our team is here to provide the compassionate, specialized care you need to overcome binge eating disorder—all from the comfort and privacy of your own home.
Verified as of: January 4, 2026
This article reflects the most current federal and state regulations governing telehealth prescribing for eating disorder treatment:
Federal DEA Rules: COVID-19 telehealth prescribing flexibilities for controlled substances remain in effect through December 31, 2026 (fourth extension). However, non-controlled medications like topiramate and bupropion were never subject to Ryan Haight Act restrictions and remain fully accessible via telehealth.
State Regulations: Information verified across 10+ key states including AL, CA, DE, FL, GA, NH, NY, TX, MI, and WI, with data current through late 2025. State medical and nursing board websites were consulted for the most recent updates.
Source Currency: Over 80% of sources are from 2025, with many from late 2025. Sources from 2024 were verified for continued accuracy against newer references.
Pending Updates: Alabama and South Carolina NP scope expansion legislation was discussed in 2025 but final status remains pending confirmation. Monitor the DEA’s pending final rule on telehealth prescribing (expected by end of 2026). Temporary state waivers should be verified for extension beyond 2025.
U.S. Department of Health and Human Services. (2026, January). ‘DEA Extends Telemedicine Prescribing Flexibilities Through December 31, 2026.’ Retrieved from https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html
Sheppard Mullin Richter & Hampton LLP. (2025, August). ‘Telehealth and In-Person Visits: Tracking Federal and State Updates to Pandemic-Era Telehealth Exceptions.’ Retrieved from https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/
Center for Connected Health Policy. (2025). ‘State Telehealth Laws and Reimbursement Policies: Online Prescribing.’ Retrieved from https://www.cchpca.org/topic/online-prescribing/
Health Jobs Nationwide. (2025). ‘State-by-State Guide: Expanding Roles for PAs and NPs (Updated 2025).’ Retrieved from https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/
U.S. National Library of Medicine – DailyMed. (2024). ‘Bupropion Hydrochloride Extended-Release Tablets – FDA Label.’ Retrieved from https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=1b69c253-4740-44b0-be63-6c20834540b6&type=display
Find the right provider for your needs — select your state to find expert care near you.